Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
10.20
0.25 (2.51%)
At close: Sep 05, 2025, 3:59 PM
10.20
0.00%
After-hours: Sep 05, 2025, 07:22 PM EDT
2.51% (1D)
| Bid | 9.09 |
| Market Cap | 909.51M |
| Revenue (ttm) | -249K |
| Net Income (ttm) | -187.6M |
| EPS (ttm) | -2.49 |
| PE Ratio (ttm) | -4.1 |
| Forward PE | -6.96 |
| Analyst | Buy |
| Ask | 10.24 |
| Volume | 1,735,826 |
| Avg. Volume (20D) | 1,562,400 |
| Open | 10.02 |
| Previous Close | 9.95 |
| Day's Range | 9.75 - 10.24 |
| 52-Week Range | 2.28 - 10.24 |
| Beta | -0.44 |
About AMLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.51%
Amylyx Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
4 months ago
+4.73%
Amylyx Pharmaceuticals shares are trading higher after Leerink Partners upgraded the stock from Market Perform to Outperform and raised its price target from $4 to $10.
